JUPITER NEUROSCIENCES, INC. Convertible Notes Payable, Current
JUPITER NEUROSCIENCES, INC. (JUNS) had Convertible Notes Payable, Current of $1.53 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-08-14
- 2026-06-30: Convertible Notes Payable, Current $1.53M.
- 2026-03-31: Convertible Notes Payable, Current $4.82M.
- 2025-12-31: Convertible Notes Payable, Current $5.30M.
- 2024-09-30: Convertible Notes Payable, Current $527.65K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2026-06-30 | $1.53M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $4.82M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $5.30M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $527.65K 10-Q · filed 2024-12-23 |
| 2023-12-31 | $1.64M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |